Theragen Receives First European Patent for ActaStim®-S
Company’s BGS Is Most Advanced Device in Category in More than Two Decades Jacksonville, FL, April 14, 2026 – Theragen, a Jacksonville, Florida–based medical device company, today announced the issuance of its first European patent (EP 4 288 138 B1), marking a major milestone in the company’s intellectual property strategy. The patent recognizes Theragen’s innovation […]
Theragen Receives First European Patent for ActaStim®-S Read More »
